Tsuneyoshi Hiroshi, Oriyanhan Wnimunk, Kanemitsu Hideo, Shiina Reiko, Nishina Takeshi, Ikeda Tadashi, Nishimura Kazunobu, Komeda Masashi
Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
ASAIO J. 2005 Jan-Feb;51(1):116-20. doi: 10.1097/01.mat.0000150325.05589.8b.
The left ventricular assist device (LVAD) is usually used in patients with end-stage heart failure as a bridge to transplantation. Recently, some studies have reported functional recovery with the use of an LVAD, although the mechanisms responsible for recovery are not fully understood. We investigated the functional recovery of the infarcted, failing rat heart in response to mechanical unloading after heterotopic transplantation. Heart failure was induced in Lewis rats by ligating the left anterior descending artery. After 4 weeks, the infarcted hearts were harvested and heterotopically transplanted. The transplanted infarcted heart was removed after 2 weeks of unloading and examined for hypertrophy and fibrosis, as well as for mRNA levels encoding for brain natriuretic peptide, sarco(endo)plasmic reticulum Ca(2+)-ATPase2a (SERCA2a), and beta1- and beta2-adrenergic receptors. Normal and infarcted rats without transplantation served as control animals. The infarcted heart was hypertrophied as evidenced by an increase in heart weight and myocyte diameter. After unloading the infarcted heart for 2 weeks, there was a decrease in heart weight and myocyte diameter. However, the percentage of myocardial fibrosis increased after unloading. The mRNA expression of brain natriuretic peptide and the beta2-adrenergic receptor significantly improved after mechanical unloading. The levels of SERCA2a mRNA tended to increase after unloading. In conclusion, unloading the failing, infarcted heart can help normalize left ventricular hypertrophy and cardiac gene expression. This unloading model appears to partially mimic the conditions of hemodynamic support with an LVAD in heart failure patients and potentially offers insights into the mechanisms of functional recovery.
左心室辅助装置(LVAD)通常用于终末期心力衰竭患者,作为移植的桥梁。最近,一些研究报告了使用LVAD后心脏功能的恢复,尽管恢复的机制尚未完全了解。我们研究了异位移植后梗死、衰竭大鼠心脏对机械卸载的功能恢复情况。通过结扎左冠状动脉前降支在Lewis大鼠中诱导心力衰竭。4周后,收获梗死心脏并进行异位移植。卸载2周后取出移植的梗死心脏,检查其肥大和纤维化情况,以及脑钠肽、肌浆网Ca(2+)-ATP酶2a(SERCA2a)、β1和β2肾上腺素能受体的mRNA水平。未进行移植的正常和梗死大鼠作为对照动物。梗死心脏出现肥大,表现为心脏重量和心肌细胞直径增加。梗死心脏卸载2周后,心脏重量和心肌细胞直径减小。然而,卸载后心肌纤维化的百分比增加。机械卸载后脑钠肽和β2肾上腺素能受体的mRNA表达显著改善。卸载后SERCA2a mRNA水平有升高趋势。总之,卸载衰竭的梗死心脏有助于使左心室肥大和心脏基因表达正常化。这种卸载模型似乎部分模拟了心力衰竭患者使用LVAD进行血流动力学支持的情况,并可能为功能恢复机制提供见解。